Who Watches the "Watchman" and How Often?

Area of Science:

• Cardiology
• Medical Devices
• Thrombosis

Background:

• Atrial fibrillation (AF) is a common arrhythmia requiring anticoagulation to prevent stroke.
• Bleeding risks often preclude anticoagulation in some AF patients.
• Left atrial appendage (LAA) closure devices, like the Watchman, offer an alternative stroke prevention strategy.

Observation:

• A patient with AF and epistaxis necessitating anticoagulation cessation underwent Watchman device implantation.
• The patient developed device-related thrombosis (DRT) post-implantation.
• This complication required extended anticoagulation and echocardiographic surveillance.

Findings:

• Device-related thrombosis (DRT) is a potential complication following LAA closure.
• There is a lack of established guidelines for monitoring DRT and determining the duration of anticoagulation after LAA device placement.
• Prolonged anticoagulation and regular echocardiographic follow-up may be necessary to manage DRT.

Implications:

• This case underscores the importance of vigilant monitoring for DRT after LAA device implantation.
• Further research is needed to establish optimal anticoagulation strategies and follow-up protocols for patients with LAA closure devices.
• Individualized patient management is crucial when balancing bleeding risks and thrombotic events in AF patients.